103 related articles for article (PubMed ID: 29749465)
1. 12(S)-HETE induces lymph endothelial cell retraction in vitro by upregulation of SOX18.
Fristiohady A; Milovanovic D; Krieger S; Huttary N; Nguyen CH; Basilio J; Jäger W; De Martin R; Krupitza G
Int J Oncol; 2018 Jul; 53(1):307-316. PubMed ID: 29749465
[TBL] [Abstract][Full Text] [Related]
2. Feed‑back loops integrating RELA, SOX18 and FAK mediate the break‑down of the lymph‑endothelial barrier that is triggered by 12(S)‑HETE.
Engleitner S; Milovanovic D; Kirisits K; Brenner S; Hong J; Ropek N; Huttary N; Rehak J; Nguyen CH; Bago-Horvath Z; Knasmüller S; De Martin R; Jäger W; Krupitza G
Int J Oncol; 2020 Apr; 56(4):1034-1044. PubMed ID: 32319559
[TBL] [Abstract][Full Text] [Related]
3. NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells.
Vonach C; Viola K; Giessrigl B; Huttary N; Raab I; Kalt R; Krieger S; Vo TP; Madlener S; Bauer S; Marian B; Hämmerle M; Kretschy N; Teichmann M; Hantusch B; Stary S; Unger C; Seelinger M; Eger A; Mader R; Jäger W; Schmidt W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Br J Cancer; 2011 Jul; 105(2):263-71. PubMed ID: 21629247
[TBL] [Abstract][Full Text] [Related]
4. AHR/CYP1A1 interplay triggers lymphatic barrier breaching in breast cancer spheroids by inducing 12(S)-HETE synthesis.
Nguyen CH; Brenner S; Huttary N; Atanasov AG; Dirsch VM; Chatuphonprasert W; Holzner S; Stadler S; Riha J; Krieger S; de Martin R; Bago-Horvath Z; Krupitza G; Jäger W
Hum Mol Genet; 2016 Nov; 25(22):5006-5016. PubMed ID: 28171546
[TBL] [Abstract][Full Text] [Related]
5. Sox18 induces development of the lymphatic vasculature in mice.
François M; Caprini A; Hosking B; Orsenigo F; Wilhelm D; Browne C; Paavonen K; Karnezis T; Shayan R; Downes M; Davidson T; Tutt D; Cheah KS; Stacker SA; Muscat GE; Achen MG; Dejana E; Koopman P
Nature; 2008 Dec; 456(7222):643-7. PubMed ID: 18931657
[TBL] [Abstract][Full Text] [Related]
6. 12(S)-HETE increases intracellular Ca(2+) in lymph-endothelial cells disrupting their barrier function in vitro; stabilization by clinical drugs impairing calcium supply.
Nguyen CH; Brenner S; Huttary N; Li Y; Atanasov AG; Dirsch VM; Holzner S; Stadler S; Riha J; Krieger S; Milovanovic D; Fristiohardy A; Simonitsch-Klupp I; Dolznig H; Saiko P; Szekeres T; Giessrigl B; Jäger W; Krupitza G
Cancer Lett; 2016 Sep; 380(1):174-83. PubMed ID: 27390016
[TBL] [Abstract][Full Text] [Related]
7. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells.
Srinivasan RS; Geng X; Yang Y; Wang Y; Mukatira S; Studer M; Porto MP; Lagutin O; Oliver G
Genes Dev; 2010 Apr; 24(7):696-707. PubMed ID: 20360386
[TBL] [Abstract][Full Text] [Related]
8. NF-κB contributes to MMP1 expression in breast cancer spheroids causing paracrine PAR1 activation and disintegrations in the lymph endothelial barrier in vitro.
Nguyen CH; Senfter D; Basilio J; Holzner S; Stadler S; Krieger S; Huttary N; Milovanovic D; Viola K; Simonitsch-Klupp I; Jäger W; de Martin R; Krupitza G
Oncotarget; 2015 Nov; 6(36):39262-75. PubMed ID: 26513020
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model.
Nguyen CH; Huttary N; Atanasov AG; Chatuphonprasert W; Brenner S; Fristiohady A; Hong J; Stadler S; Holzner S; Milovanovic D; Dirsch VM; Kopp B; Saiko P; Krenn L; Jäger W; Krupitza G
Int J Oncol; 2017 May; 50(5):1879-1888. PubMed ID: 28393180
[TBL] [Abstract][Full Text] [Related]
10. Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA interaction.
Klaus M; Prokoph N; Girbig M; Wang X; Huang YH; Srivastava Y; Hou L; Narasimhan K; Kolatkar PR; Francois M; Jauch R
Nucleic Acids Res; 2016 May; 44(8):3922-35. PubMed ID: 26939885
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterisation of the anti-intravasative properties of the marine product heteronemin.
Kopf S; Viola K; Atanasov AG; Jarukamjorn K; Rarova L; Kretschy N; Teichmann M; Vonach C; Saiko P; Giessrigl B; Huttary N; Raab I; Krieger S; Schumacher M; Diederich M; Strnad M; de Martin R; Szekeres T; Jäger W; Dirsch VM; Mikulits W; Grusch M; Dolznig H; Krupitza G
Arch Toxicol; 2013 Oct; 87(10):1851-61. PubMed ID: 23543012
[TBL] [Abstract][Full Text] [Related]
12. Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier
Hong J; Fristiohady A; Nguyen CH; Milovanovic D; Huttary N; Krieger S; Hong J; Geleff S; Birner P; Jäger W; Özmen A; Krenn L; Krupitza G
Front Pharmacol; 2018; 9():220. PubMed ID: 29593542
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumour spheroid-induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model.
Teichmann M; Kretschy N; Kopf S; Jarukamjorn K; Atanasov AG; Viola K; Giessrigl B; Saiko P; Szekeres T; Mikulits W; Dirsch VM; Huttary N; Krieger S; Jäger W; Grusch M; Dolznig H; Krupitza G
Arch Toxicol; 2014 Mar; 88(3):691-9. PubMed ID: 24352538
[TBL] [Abstract][Full Text] [Related]
14. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
15. LPS-induced Acute Lung Injury Involves NF-κB-mediated Downregulation of SOX18.
Gross CM; Kellner M; Wang T; Lu Q; Sun X; Zemskov EA; Noonepalle S; Kangath A; Kumar S; Gonzalez-Garay M; Desai AA; Aggarwal S; Gorshkov B; Klinger C; Verin AD; Catravas JD; Jacobson JR; Yuan JX; Rafikov R; Garcia JGN; Black SM
Am J Respir Cell Mol Biol; 2018 May; 58(5):614-624. PubMed ID: 29115856
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell-derived 12(S)-HETE signals via 12-HETE receptor, RHO, ROCK and MLC2 to induce lymph endothelial barrier breaching.
Nguyen CH; Stadler S; Brenner S; Huttary N; Krieger S; Jäger W; Dolznig H; Krupitza G
Br J Cancer; 2016 Jul; 115(3):364-70. PubMed ID: 27362730
[TBL] [Abstract][Full Text] [Related]
17. Suppression of SOX18 by siRNA inhibits cell growth and invasion of breast cancer cells.
Zhang J; Ma Y; Wang S; Chen F; Gu Y
Oncol Rep; 2016 Jun; 35(6):3721-7. PubMed ID: 27108946
[TBL] [Abstract][Full Text] [Related]
18. Xanthohumol attenuates tumour cell-mediated breaching of the lymphendothelial barrier and prevents intravasation and metastasis.
Viola K; Kopf S; Rarova L; Jarukamjorn K; Kretschy N; Teichmann M; Vonach C; Atanasov AG; Giessrigl B; Huttary N; Raab I; Krieger S; Strnad M; de Martin R; Saiko P; Szekeres T; Knasmüller S; Dirsch VM; Jäger W; Grusch M; Dolznig H; Mikulits W; Krupitza G
Arch Toxicol; 2013 Jul; 87(7):1301-12. PubMed ID: 23503627
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
Kretschy N; Teichmann M; Kopf S; Atanasov AG; Saiko P; Vonach C; Viola K; Giessrigl B; Huttary N; Raab I; Krieger S; Jäger W; Szekeres T; Nijman SM; Mikulits W; Dirsch VM; Dolznig H; Grusch M; Krupitza G
Br J Cancer; 2013 Feb; 108(3):570-8. PubMed ID: 23299527
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction.
Honn KV; Tang DG; Grossi I; Duniec ZM; Timar J; Renaud C; Leithauser M; Blair I; Johnson CR; Diglio CA
Cancer Res; 1994 Jan; 54(2):565-74. PubMed ID: 8275495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
